Purple Biotech Ltd (KTOV) - Cash Flow Conversion Efficiency

Latest as of June 2020: -0.041x

Based on the latest financial reports, Purple Biotech Ltd (KTOV) has a cash flow conversion efficiency ratio of -0.041x as of June 2020. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-2.32 Million ≈ $-6.22K USD) by net assets (ILA56.15 Million ≈ $150.52K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Purple Biotech Ltd to measure how much of total assets are equity-financed.

Purple Biotech Ltd - Cash Flow Conversion Efficiency Trend (2013–2019)

This chart illustrates how Purple Biotech Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore how well can Purple Biotech Ltd service its debt to assess how comfortably operating cash covers total debt obligations.

Purple Biotech Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Purple Biotech Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ariana Resources plc LSE:AAU	-0.024x
MOVEBYBIKE EUROPE AB F:6ZR	-7.892x
Groupimo SA PA:ALIMO	0.025x
SDCL EDGE Acquisition Corporation NYSE:SEDA	-0.009x
Time Out Group plc LSE:TMO	-0.052x
Mongolia Growth Group Ltd. V:YAK-H	-0.015x
SECITS Holding AB (publ) ST:SECI	0.666x
Tinybuild Inc LSE:TBLD	0.161x

Annual Cash Flow Conversion Efficiency for Purple Biotech Ltd (2013–2019)

The table below shows the annual cash flow conversion efficiency of Purple Biotech Ltd from 2013 to 2019. For the full company profile with market capitalisation and key ratios, see Purple Biotech Ltd (KTOV) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2019-12-31	ILA10.86 Million ≈ $29.11K	ILA-5.58 Million ≈ $-14.96K	-0.514x	+33.31%
2018-12-31	ILA11.00 Million ≈ $29.50K	ILA-8.48 Million ≈ $-22.73K	-0.771x	+23.24%
2017-12-31	ILA8.59 Million ≈ $23.04K	ILA-8.63 Million ≈ $-23.13K	-1.004x	-114.60%
2016-12-31	ILA13.38 Million ≈ $35.88K	ILA-6.26 Million ≈ $-16.79K	-0.468x	-33.35%
2015-12-31	ILA9.43 Million ≈ $25.28K	ILA-3.31 Million ≈ $-8.87K	-0.351x	+93.40%
2014-12-31	ILA851.00K ≈ $2.28K	ILA-4.53 Million ≈ $-12.13K	-5.318x	-1082.67%
2013-12-31	ILA-946.00K ≈ $-2.54K	ILA-512.00K ≈ $-1.37K	0.541x	--

About Purple Biotech Ltd

TA:KTOV Israel Biotechnology & Medical Research

Market Cap

$461.41K

ILA172.11 Million ILA

Market Cap Rank

#30949 Global

#459 in Israel

Share Price

ILA1.00

Change (1 day)

+0.00%

52-Week Range

ILA1.00 - ILA3.90

All Time High

ILA4180.00